WANDA GARCIA MACIAS: Open Payments
NPI 1861183162 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 17 payments from 12 companies in 2025. Trend: 2023 $110 · 2024 $367 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 3 | $71 |
| Medtronic, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Amgen Inc. | 2 | $34 |
| Verona Pharma, Inc. | 1 | $32 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
| Eisai Inc. | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
Products named: SYMPLICITY G3, OPSUMIT, BENLYSTA, TEZSPIRE, Ohtuvayre, PURIFIED CORTROPHIN GEL, OPSYNVI, Leqembi.
Industry payments across AZ — which companies pay providers there.
